Introduction {#Sec1}
============

Non-communicable diseases (NCDs) have become an issue of worldwide concern and have been clearly identified as a problem to be addressed according to the Sustainable Development Goals by the United Nations \[[@CR1]\]. Additionally, NCDs are predicted to cause half of all deaths in most developing countries by 2030 \[[@CR2]\]. These countries are also disproportionately affected by communicable diseases \[[@CR3]\]; therefore, preventive measures are needed to minimize the double burden of communicable and non-communicable diseases.

Since anti-retroviral therapy (ART) was introduced to treat human immunodeficiency virus (HIV) infection, comorbidities affecting individuals with HIV infection have changed dramatically, with increasing prevalence of overweight and obesity \[[@CR4]\] and NCDs \[[@CR5]\]. HIV-infected individuals are no longer seriously affected by wasting syndrome; instead, the prevalence of overweight/obesity has been increasing \[[@CR4], [@CR6]\]. Such changes necessitate measures to prevent NCDs that target individuals with HIV infection as well as the general population, particularly in sub-Saharan Africa where more than two thirds of the global population of HIV-infected individuals resides \[[@CR7]\]. Previous studies in Kenya have reported a lower prevalence of overweight/obesity and hypertension among HIV-infected people than in the general population and in those without HIV infection \[[@CR8], [@CR9]\]. However, the situation among Kenyans with HIV infection may have changed since the publication of those reports, as has been the case in South Africa \[[@CR10], [@CR11]\]. Overweight/obesity is a known risk factor for NCDs and is an important issue to address in NCD prevention. Yet challenges remain with respect to reducing overweight/obesity among HIV-infected individuals in African countries, where a plump figure is desirable \[[@CR12], [@CR13]\] and where AIDS has been thought of as a wasting syndrome \[[@CR14]\].

In this study, we aimed to determine the prevalence of overweight/obesity and abdominal obesity as well as hypertension among HIV-infected individuals in Western Kenya and to identify the risk factors of overweight/obesity, abdominal obesity, and hypertension.

Methods {#Sec2}
=======

Study design {#Sec3}
------------

We conducted a cross-sectional study in Mbita, Homa Bay County, Kenya, from September to December 2015. HIV-infected adults were recruited at Mbita Sub-county Hospital and were administered a structured questionnaire as well as anthropometric (weight, height, and waist circumference) and blood pressure measurement.

Participants and sample size {#Sec4}
----------------------------

HIV-infected adults in this study were defined as individuals aged 18 years and older, who had tested positive for HIV infection, were enrolled at the Patient Support Center (PSC) in Mbita Sub-county Hospital for more than 1 year at the time of the study, and had medical records available that included the results of HIV viral load counts within the previous 18 months. All eligible participants at the PSC on the research day were recruited. We excluded individuals who were pregnant; taking hormonal medication, except for contraceptives; and those who were hospitalized.

The sample size was calculated based on the expected prevalence obtained from a previous study conducted among HIV-infected people in Western Kenya where the overall prevalence of overweight and obesity was 18.3% in both men and women \[[@CR9]\]. We applied the formula of sample size for a prevalence study with a cross-section design \[[@CR15]\], with 0.183 as the expected prevalence, 95% confidence interval (CI) of 1.96, and a margin of error of 0.05 for precision. The calculated sample size was 227. Considering a 10% non-response rate, 251 participants were recruited during the study period.

Variables {#Sec5}
---------

The main dependent variables were body mass index (BMI), waist circumference (WC), and blood pressure. Weight was measured to the nearest 0.1 kg, height to the nearest 1 mm, and WC to the nearest 1 cm. Blood pressure was measured once using a digital sphygmomanometer (HEM-7132; OMRON, Kyoto, Japan). BMI ≤ 18.5 was classified as underweight, BMI ≥ 25 as overweight, and BMI ≥ 30 as obese \[[@CR16]\]. For the analysis, overweight and obesity were combined for outcome and designated as overweight. Abdominal obesity was defined as WC ≥ 94 cm for men and ≥ 80 cm for women \[[@CR17]\]. The definition of hypertension followed the World Health Organization (WHO) criteria, with diastolic pressure ≥ 90 mmHg or systolic pressure ≥ 140 mmHg \[[@CR18]\].

Independent variables were collected using a questionnaire and medical records. The questionnaire comprised demographic information including socioeconomic status (SES), dietary habits, physical activity, and perception of body size in relation to HIV/AIDS. Alcohol use and smoking were also queried (yes or no) in the questionnaire. The following clinical variables were obtained from the medical records: WHO clinical stage of HIV/AIDS \[[@CR19]\], intake and duration of ART and protease inhibitors (PIs), CD4 counts, viral load, history of opportunistic infections, and history of the use of tuberculosis medication and contraceptives. We collected information of any type of opportunistic infection noted by a clinician in participants' medical records.

In the analysis, education level was recategorized as follows: "No education" and "Incomplete primary school" were recategorized into "low education," "Complete primary school" was retained, and "Complete secondary school" and "higher education" were recategorized into "Complete secondary or higher." Occupation was also recategorized according to level of the physical activity as follows. "Not working," "Housework," and "Student" were recategorized into "At home"; "Farmer" and "Fisherman" into "Working outside"; and "Office work," "Engineer," "Small business entrepreneur," and "Tailor" into "Working inside." Other occupations including driver and carpenter were retained as "others." An SES indicator was generated by summing asset ownership, after principal component analysis was applied to weight each asset (car, refrigerator, television, iron, mobile phone, radio, bicycle, sofa, livestock, and poultry). This was divided into four categories according to 25th, 50th, and 75th percentiles and labeled in order from "poorest," "poor," "less poor," to "rich."

The questionnaire was translated into the local language, Dholuo, then back-translated into English to check for consistency. The questionnaire was modified as required after pre-testing among 40 people who were eligible for participation in the study.

Physical activity level {#Sec6}
-----------------------

Physical activity level during the previous 7 days was assessed using the self-administered International Physical Activity Questionnaire for young and middle-aged adults \[[@CR20]\]. This instrument has been validated in many countries, including South Africa \[[@CR20], [@CR21]\]. Physical activity was categorized into three levels: inactive, minimally active, and health-enhancing physical activity (HEPA).

Perception of body size (body image) {#Sec7}
------------------------------------

Participants' perception of body size in relation to HIV/AIDS was assessed using nine illustrations of different body figures, which was presented by Lynch et al. in 2009 \[[@CR22]\].

Statistical analysis {#Sec8}
--------------------

Descriptive analysis was conducted to determine the prevalence of overweight, abdominal obesity, and hypertension along with stratification by age and sex, and for key characteristics among participants. First, the association of overweight, abdominal obesity, and hypertension with each independent variable was examined using bivariate analysis by calculating the crude odds ratio (OR) and 95% CI. Then, the OR of each variable was adjusted by age, sex, and SES in multivariable logistic regression analysis to identify the adjusted odds ratio (aOR) and 95% CI. The statistical significance was set as *P* value = 0.05. The statistical analysis was conducted using MedCalc version 19.1.7.

Results {#Sec9}
=======

Background data of participants {#Sec10}
-------------------------------

A total 251 participants were enrolled from among those registered at PSC in Mbita Sub-county Hospital. As the total number of those registered at this hospital as of September to December in 2015 was unavailable, it was difficult to determine the response rate. Participants' characteristics are shown in Table [1](#Tab1){ref-type="table"}. The median age was 38 years with an interquartile range of 32--45 years. All participants had taken ART, most for 1 year or longer. Approximately 75% of participants had a history of tuberculosis, and fewer than 20% had a past history of other opportunistic infections. Viral load was less than 150 copies/ml in approximately 80% of participants. Table 1Participant characteristicsNumberPercentageNumberPercentageAge18--1910.4Socioeconomic statusPoorest6325.120--293212.7Poor6224.730--3910441.4Less poor6224.740 and older11445.4Rich6325.1Missing data1SexMale8232.7AlcoholNo22386.7Female16967.3Education levelNo education114.4Yes249.7Missing data4Low education8533.9SmokeNo24296.4Complete primary11746.6Complete secondary3012.0Yes93.6Higher education83.2Contraceptive useNo7128.3OccupationNot working2610.4Yes18071.7Housework52.0Missing data4Farmer176.8Opportunistic infection historyNo20481.9Fisherman3112.4Office work31.2Yes4518.1Engineer10.4Missing data2Small entrepreneur12549.8Tuberculosis historyNo6626.3Tailor72.8Yes18573.7Student00.0CD4 counts (cells/μl)Less than 2003012.1Other3614.3On anti-retroviral therapy (ART)No00.0Yes251100.0200--49911345.4500 and higher10642.6ART duration0--14 days00.0Missing data214--55 days10.4Viral load (copies/ml)Less than 15020682.456--181 days00.0182--364 days135.2150 and higher4417.6365 days and more23794.4Missing data1On protease inhibitorsNo21485.3WHO stage15120.3Yes3614.327128.3Missing data139738.6Protease inhibitor duration0--539 days72.842911.6Missing data3540 days and more2811.2Missing data1*N* number of study participants, *n* number of elements in a sample. Alcohol use and smoking were also asked as yes or no in the questionnaire. Contraceptive use: hormonal contraceptive use among women. WHO stage: WHO clinical staging of HIV/AIDS for adults and adolescents

Prevalence of overweight, abdominal obesity, and hypertension {#Sec11}
-------------------------------------------------------------

More HIV-infected women were overweight than underweight; only 8.3% of HIV-infected women were underweight whereas 17.2% were overweight and 3.6% were obese. Among HIV-infected men, slightly more were underweight (12.2%) than overweight (11.0%), and none were obese (data not shown in the table).

The prevalence of overweight, abdominal obesity, and hypertension according to different sex and age groups is shown in Table [2](#Tab2){ref-type="table"}. The prevalence of overweight was higher at age 30 years and older. Abdominal obesity was much more common in women (62.1%) than in men (9.6%), with nearly 70% of women aged 30--39 years having abdominal obesity. The prevalence of hypertension in all age groups was 9.8% and 11.8% among men and women, respectively. Men tended to develop hypertension at early ages. Table 2Prevalence of overweight, abdominal obesity, and hypertension according to sex and age groupOverweightAbdominal obesityHypertensionAge*Nn*%*Nn*%*Nn*%Male All ages82911.08278.58289.8 18--19000000.0000.0 20--297007114.37114.3 30--3928310.73425.928414.3 40 and older47612.841512.24736.4Female All ages1693520.716910562.11692011.8 18--19100100.0100 20--2925312.02515602528.0 30--39761722.4704868.67645.3 40 and older671522.4734257.5671420.9Overweight includes obesity. Hypertension includes both high systolic blood pressure and diastolic blood pressure. *N* number of study participants, *n* number of elements in a sample

Factors associated with overweight, abdominal obesity, and hypertension {#Sec12}
-----------------------------------------------------------------------

The results of bivariate and multivariate analysis for overweight are shown in Table [3](#Tab3){ref-type="table"}. A history of opportunistic infections was significantly associated with overweight (OR 2.46, 95% CI 1.10--5.50, *P* = 0.028). Overweight was more common in women (19.5%) than in men (11.0%), although no association was identified. Table 3Factors associated with overweight*Nn*%OR95% CI*P* valueaOR95% CI*P* valueAge category 18--2933412.11.001.00 30--391042019.21.720.545.470.3531.990.616.460.251 40 and older1141815.81.350.424.330.6041.430.444.660.545Sex Male82911.01.001.00 Female1693319.51.960.894.330.0932.110.944.720.070Marital status Single7228.61.001.00 Married1542516.20.480.082.630.4020.530.093.050.478 Divorced10110.00.270.013.880.3410.380.025.690.484 Widowed801417.50.530.093.020.4740.580.093.510.558Education level Low education961414.61.001.00 Complete primary1172218.81.350.652.820.4141.590.743.440.229 Complete secondary or higher38615.81.090.383.110.8591.590.505.040.429Occupation At home31516.11.001.00 Working outside481020.81.360.414.470.6031.360.404.590.620 Working inside1362014.70.890.312.610.8410.830.272.470.738 Others36719.41.260.354.440.7241.290.344.820.695SES Poorest631320.61.001.00 Poor62914.50.650.251.660.3710.670.261.740.419 Less poor621321.01.020.432.420.9630.950.392.310.926 Rich63711.10.480.171.300.14910.420.151.160.096Physical activity level Inactive11218.21.001.00 Minimally active22418.21.000.156.5310.920.136.290.933 HEPA active2153616.70.910.184.360.90110.800.154.040.791Chai per day 0--1 cup20315.01.001.00 2 cups581119.01.320.325.330.6911.190.284.940.803 3 cups or more1732816.21.090.303.980.89130.960.253.630.963Soda per week None1262318.31.001.00 Once64710.90.550.221.360.1960.490.191.250.141 Twice or more611219.71.100.502.380.81570.990.442.210.984Ugali per day Quarter a plate1853217.31.001.00 Half a plate55814.50.810.351.880.6310.970.402.310.946 3 quarters a plate or more8112.50.680.085.740.72570.740.086.600.789Alcohol No2233515.71.001.00 Yes24520.81.410.494.030.51791.660.545.040.367Smoke No2424116.91.001.00 Yes9111.10.610.075.030.6480.910.108.200.935Abdominal obesity No1382115.21.001.00 Yes1132118.61.270.652.460.4770.940.432.030.885Hypertension No2223515.81.001.00 Yes28725.01.780.704.510.2232.040.775.390.147ART duration 0--364 days14428.61.001.00 365 days and more2373816.00.480.141.600.2310.520.151.840.314CD4 counts (cells/μl) \< 20030310.01.001.00 200--4991132017.71.930.537.010.3152.080.557.790.276 ≥ 5001061917.91.960.547.150.30531.940.517.310.326On PI No2143918.21.001.00 Yes3625.60.410.111.390.15370.450.121.570.323PI duration 0--359 days7114.31.001.00 540 days and more2827.10.460.035.960.5530.999WHO stage 151815.71.001.00 2711723.91.690.664.290.2681.850.714.860.208 3971212.40.750.281.990.5760.740.272.020.563 429517.21.110.323.810.85621.040.283.790.946OI history No2043014.71.001.00 Yes451226.72.110.984.530.05622.461.105.500.028*N* number of study participants, *n* number of elements in a sample, *OR* odds ratio, *95% CI* 95% confidential interval, *aOR* adjusted odds ratio, *P value* probability value, *HEPA* health-enhancing physical activity, *ART* anti-retroviral therapy, *PI* protease inhibitor, *WHO stage* WHO clinical staging of HIV/AIDS for adults and adolescent, *OI* opportunistic infection

The results of bivariate and multivariate analysis for abdominal obesity are shown in Table [4](#Tab4){ref-type="table"}. We identified an association between abdominal obesity and female sex (aOR 15.28, 95% CI 6.84--34.12, *P* \< 0.0001). Abdominal obesity was more common in participants with a history of opportunistic infections (53.3%) than in those without this history (43.1%), although no association was identified. Other factors including level of physical activity was not significantly associated with either overweight or abdominal obesity. Table 4Factors associated with abdominal obesity*Nn*%OR95% CI*P* valueaOR95% CI*P* valueAge category 18--29331648.51.001.00 30--391045048.10.980.442.150.9671.300.533.190.558 40 and older1144741.20.740.341.660.4591.060.4422.540.896Sex Male8289.81.001.00 Female16910562.115.176.8633.53\< 0.000115.286.8434.12\< 0.0001Marital status Single7342.911 Married1547146.11.140.245.260.8661.940.3510.570.441 Divorced10440.00.880.126.310.9062.110.2120.420.516 Widowed803543.81.030.214.930.9632.180.3712.680.382Education level Low education964142.71.001.00 Complete primary1175143.61.030.601.780.8970.860.451.670.676 Complete secondary or higher382155.31.650.773.530.191.340.503.610.551Occupation At home311548.41.001.00 Working outside482347.90.980.392.420.9670.790.262.400.685 Working inside1365741.90.760.351.680.5110.630.241.670.360 Others361850.01.060.402.780.8950.570.171.850.357SES Poorest632336.51.001.00 Poor622337.11.020.492.120.9450.990.432.280.990 Less poor623251.61.850.903.790.0901.540.683.510.294 Rich633555.62.171.064.440.0331.990.864.600.104Physical activity level Inactive11654.51.00 Minimally active22940.90.570.132.480.460.400.072.280.302 HEPA active2159745.10.680.202.310.5420.550.122.400.429Chai per day 0--1 cup20840.01.001.00 2 cups582746.61.300.463.660.6111.140.324.050.836 3 cups or more1737845.11.230.473.160.6650.870.272.790.827Soda per week None1265846.01.001.00 Once642742.20.850.461.570.6140.660.321.340.255 Twice or more612845.90.990.531.830.9860.960.462.030.933Ugali per day Quarter a plate1859149.21.001.00 Half a plate551934.50.540.291.010.0570.600.281.270.186 3 quarters a plate or more8225.00.340.061.750.1980.360.041.270.205Alcohol No22310346.21.001.00 Yes24833.30.580.231.410.2331.160.383.520.792Smoke No24211246.31.001.00 Yes9111.10.140.011.170.070.520.045.540.590Abdominal obesity No2099244.01.001.00 Yes422150.01.270.652.460.4770.950.442.090.900Hypertension No2229743.71.001.00 Yes281657.11.710.773.800.1811.720.654.530.272ART duration 0--364 days14964.31.001.00 365 days and more23710443.90.430.141.330.1450.340.081.390.136CD4 counts (cells/μl) \< 200301550.01.001.00 200--4991135044.20.790.351.770.5741.040.412.650.927 ≥ 5001064845.30.820.361.860.6471.070.412.750.885On PI No2149544.41.001.00 Yes361850.01.250.612.530.5321.820.744.440.187PI duration 0--359 days7342.91.001.00 540 days and more281553.61.530.288.180.6130.040.002.600.131WHO stage 1512039.21.001.00 2713752.11.680.813.500.1602.370.975.730.056 3974041.21.080.542.170.8111.140.512.580.736 4291551.71.660.664.160.2791.850.615.570.269OI history No2048843.11.001.000 Yes452453.31.500.782.870.2152.210.975.020.057*N* number of study participants, *n* number of elements in a sample, *OR* odds ratio, *95% CI* 95% confidential interval, *aOR* adjusted odds ratio, *P value* probability value, *HEPA* health-enhancing physical activity, *ART* anti-retroviral therapy, *PI* protease inhibitor, *WHO stage* WHO clinical staging of HIV/AIDS for adults and adolescents, *OI* opportunistic infection

The results of bivariate and multivariate analysis with hypertension are shown in Table [5](#Tab5){ref-type="table"}. We identified an association between hypertension and WHO clinical stage. WHO clinical stage 3 was less strongly associated with hypertension than WHO clinical stage 1 (aOR 0.18, 95% CI 0.05--0.58, *P* \< 0.01), as was the case for WHO clinical stage 4 in comparison with WHO clinical stage 1 (aOR 0.16, 95% CI 0.02--0.87, *P* \< 0.05). Table 5Factors associated with hypertension*Nn*%OR95% CI*P* valueaOR95% CI*P* valueAge category 18--293339.11.001.00 30--3910487.70.830.213.340.7970.750.183.080.308 40 and older1131715.01.770.486.450.3871.930.517.230.952Sex Male8189.91.001.00 Female1692011.81.220.512.910.6461.230.512.990.645Marital status Single700.01.001.00 Married1541711.00.9990.999 Divorced1000.01.001.0001.000 Widowed791113.91.000.9990.999Education level Low education961313.51.001.00 Complete primary116119.50.660.281.560.3550.590.231.470.260 Complete secondary or higher38410.50.750.222.460.6370.420.111.710.229Occupation At home3126.51.001.00 Working outside4848.31.310.227.660.7591.350.228.110.741 Working inside1351712.62.080.459.550.3421.980.429.350.387 Others36513.92.330.4213.010.3321.790.3110.490.516SES Poorest63711.11.001.00 Poor6246.50.550.151.980.3630.510.141.860.308 Less poor62711.31.010.333.090.9750.960.312.980.952 Rich621016.11.530.544.330.4141.780.615.170.289Physical activity level Inactive11218.21.001.00 Minimally active2229.10.450.053.710.4590.460.054.010.482 HEPA active2142411.20.560.112.780.4860.460.082.430.364Chai per day 0--1 cup2000.01.001.00 2 cups5811.70.9980.998 3 cups or more1722715.70.9970.998Soda per week None1251915.21.001.00 Once6446.30.370.121.140.0850.410.131.290.130 Twice or more6158.20.490.171.410.1880.570.201.660.311Ugali per day Quarter a plate1842413.01.001.00 Half a plate5547.30.520.171.570.2500.500.161.540.230 3 quarters a plate or more800.00.9980.998Alcohol No2222410.81.001.00 Yes24312.51.170.324.240.8021.350.355.230.661Smoke No2412811.61.001.00 Yes900.00.9980.998Overweight/obesity No2082110.11.001.00 Yes42716.71.780.704.510.2231.950.745.130.173Abdominal obesity No137128.81.00 Yes1131614.21.710.664.420.261ART duration 0--364 days14214.31.001.00 365 days and more2362611.01.710.773.800.1820.510.102.590.424CD4 counts (cells/μl) \< 20030310.01.001.00 200--4991131311.51.170.314.400.8161.510.385.950.555 ≥ 5001051211.41.160.314.410.8261.620.406.560.495On PI No2142612.11.001.00 Yes3525.70.430.091.930.2760.390.081.810.234PI duration 0--359 days700.01.001.00 540 days and more2727.40.9980.999WHO stage 1511019.61.001.00 2711014.10.670.251.750.4140.520.181.440.211 39666.30.270.090.800.0180.180.050.580.004 42926.90.300.061.490.1430.160.020.870.034OI history No2042110.31.001.00 Yes44715.91.640.654.150.2901.520.574.000.396*N* number of study participants, *n* number of elements in a sample, *OR* odds ratio, *95% CI* 95% confidential interval, *aOR* adjusted odds ratio, *P value* probability value, *HEPA* health-enhancing physical activity, *ART* anti-retroviral therapy, *PI* protease inhibitor, *WHO stage* WHO clinical staging of HIV/AIDS for adults and adolescents, *OI* opportunistic infection

Perceptions of body size {#Sec13}
------------------------

More than half of HIV-infected participants (*n* = 150; 60%) assumed that the thinnest among the nine body figures was indicative of HIV infection whereas 37.6% (*n* = 94) did not make this assumption for any of the body figures. Only 1.6 % (*n* = 4) assumed that the largest figure was indicative of HIV infection. Perception of a thin body figure as indicating HIV infection was significantly associated with personal experience of or witnessing discrimination against HIV-infected people (OR 3.67, 95% CI 2.36--5.69, *P* \< 0.001). However, no association was found between an experience of discrimination and overweight (OR 1.84, 95% CI 0.94--3.16, *P* = 0.070) or experience of discrimination and abdominal obesity (OR 1.25, 95% CI 0.74--2.12, *P* = 0.398).

Discussion {#Sec14}
==========

The findings of this study highlight the current situation regarding body weight and blood pressure among HIV-infected individuals in Western Kenya.

Overweight was much more prevalent than underweight among women in this study. Moreover, we observed a high prevalence of abdominal obesity among women. First, the second regimen of ART, or PIs, is known to cause metabolic side effects including abdominal obesity \[[@CR23]\]; however, only a few individuals in our study population had taken PIs. A high prevalence of abdominal obesity among HIV-infected women who were not taking PIs is compatible with the findings of a previous study reporting a positive association between abdominal obesity and HIV infection with an ART regimen, even with minor metabolic side effects \[[@CR24]\]. Second, abdominal obesity among women was defined as WC ≥ 80 cm \[[@CR17]\]; however, this cutoff point is controversial \[[@CR25]--[@CR29]\]. The WC cutoff point for abdominal obesity among sub-Saharan African populations is based on the cutoff point obtained from studies conducted among European populations \[[@CR17]\]. A study targeting HIV-infected people in South Africa determined that 90 cm was an optimal cutoff point \[[@CR29]\]. Furthermore, the combined use of WC and hip circumference could more effectively predict an increased health risk among HIV-infected individuals than use of WC alone \[[@CR30]\]. Therefore, further investigation using different cutoff points and measurement methods is desirable.

Only female sex was found to be a risk factor of abdominal obesity, which is in agreement with a previous study \[[@CR24]\]. In our study, no other potential associations were found for other dependent variables such as high SES, being married, and older age, as have been reported in previous studies \[[@CR10], [@CR31]\]. A possible reason for this might be bias and a small study population with similar lifestyles and economic levels. Consumption of sugar-sweetened beverages is a well-known risk factor of overweight/obesity in the general population \[[@CR32]\]; however, we found no association between consumption of soda or chai and overweigh/obesity in our study population, despite the fact that drinking chai is an integral aspect of Kenyan culture. Physical activity was not found to be associated with a decreased risk of overweight/obesity in this study, despite being widely known as a preventive factor for overweight/obesity and hypertension \[[@CR33]\]. Most participants had HEPA levels of physical activity, which implies that people throughout the study area have similar lifestyles. This could explain the lack of an association between chai or soda consumption and overweight/obesity, as high energy consumption was accompanied by high activity levels.

An association of overweight with a history of opportunistic infections was revealed in this study. Studies on the association between overweight/obesity and opportunistic infections are limited, and the precise relationship between them remains unknown. However, a previous report noted that the presence of an opportunistic infection decreased the likelihood of overweight/obesity \[[@CR34]\]. Furthermore, an association between higher BMI and higher CD4 counts was reported in a past study \[[@CR35]\], which may lessen the likelihood of acquiring an opportunistic infection. However, some evidence of a relationship between obesity and inflammation, such as surgical-site infections, nosocomial infections, periodontitis, and skin infections, has been established \[[@CR36]\]. In our study, a causal relationship could not be established owing to the cross-sectional study design. There is a possibility that participants had opportunistic infections at the time of HIV diagnosis or on beginning ART. Then, opportunistic infections were treated and the individual regained weight afterward because ART initiation has been reportedly associated with overweight/obesity \[[@CR4]\]. Further research is needed to follow weight change and the occurrence of opportunistic infections or other events, to identify the risk and outcomes of overweight/obesity.

In our study population, perceptions about body size may remain problematic. Most people associated the thinnest body figure as indicative of HIV infection, having remembered wasting disease during the initial stages of the HIV/AIDS outbreak \[[@CR14]\]. This perception might also be reinforced by experiences of discrimination or observing discrimination against people who are thin. In fact, participants who had such experiences were more likely to perceive a thin body figure as indicative of HIV infection.

The findings of this study highlight the necessity of intervention to prevent and decrease overweight and abdominal obesity among people living with HIV as well as among the general population. Our study adds several important points to the knowledge base in this regard. Understanding local beliefs and concepts is important when introducing any new approach to health. Continuous monitoring and further investigation are also necessary because the physical condition of HIV-positive individuals, including their nutritional status, may change according to ART outcome and lifestyle changes.

This study has several limitations. First, we did not include an HIV-negative group for comparison, so it was difficult to identify those factors only affecting people with HIV infection. Second, the data used in this study do not represent the population of the entire study area because the study location and participants were not randomly selected. Third, we failed to recruit a sufficient number of participants to conduct efficient statistical analysis because of the limited study period. Lastly, owing to technical differences and time management issues, we could not measure hip circumference, to obtain the waist-to-hip ratio, which is often used to assess cardiovascular risk in people with HIV infection. Despite these limitations, our study provides informative insights, adding to the knowledge gained in early studies on NCDs and HIV infection on the African continent.

Conclusion {#Sec15}
==========

HIV-infected women were more likely to be overweight or obese than underweight whereas the men with HIV infection in our study tended to be underweight. Abdominal obesity was much common in women, especially among those in their 30s. Female sex and a history of opportunistic infections were identified as risk factors of abdominal obesity and overweight, respectively, and we identified a negative association between hypertension and WHO clinical stage. More than half of participants assumed a thin body figure indicated HIV infection, although none of the assessed factors was significantly associated with this assumption. HIV-infected individuals, especially women, should be targeted in preventive interventions for overweight and abdominal obesity, with consideration of relevant social and cultural aspects. In addition, continuous monitoring and further investigation are necessary as the physical and clinical condition of people living with HIV, including their nutritional status, may change according to ART outcome and lifestyle changes.
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